LIU Si- yang, ZHANG Chao. Efficacy of EGFR Tyrosine Kinase Inhibitors in The Adjuvant Treatment for Operable Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2017, 17(5): 261-262. DOI: 10.12019/j.issn.1671-5144.2017.05.004
|
Citation:
|
LIU Si- yang, ZHANG Chao. Efficacy of EGFR Tyrosine Kinase Inhibitors in The Adjuvant Treatment for Operable Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2017, 17(5): 261-262. DOI: 10.12019/j.issn.1671-5144.2017.05.004
|
LIU Si- yang, ZHANG Chao. Efficacy of EGFR Tyrosine Kinase Inhibitors in The Adjuvant Treatment for Operable Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2017, 17(5): 261-262. DOI: 10.12019/j.issn.1671-5144.2017.05.004
|
Citation:
|
LIU Si- yang, ZHANG Chao. Efficacy of EGFR Tyrosine Kinase Inhibitors in The Adjuvant Treatment for Operable Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2017, 17(5): 261-262. DOI: 10.12019/j.issn.1671-5144.2017.05.004
|
DownLoad: